InvestorsHub Logo

DaubersUP

08/25/18 12:04 PM

#238390 RE: DaubersUP #238388

I believe we hit the 33% at 12 weeks. I believe patients would scream for an oral that is 1000x safer and works 4 weeks quicker. All in one of the hottest sectors in Pharm right now.
Everyone cares about appearance these days.

georgejjl

08/25/18 1:39 PM

#238398 RE: DaubersUP #238388

For the Phase 2 Otezla trial CC-10004-PSOR-004

...It is important to note that the proportion of subjects achieving PASI-75 (30%) is similar to the 24.3% seen in Study CC-10004-PSOR-003, where subjects could not enter the trial if they had failed therapy with cyclosporine pr biologic therapy....



https://media.celgene.com/content/uploads/CC-10004-PSOR-004-Synopsis-Redacted.pdf

Expect much better results from Prurisol 150 mg BID and 200 mg BID.

https://clinicaltrials.gov/ct2/show/NCT02949388?term=NCT02949388&rank=1

Good luck and GOD bless,

George